Webbplatsen kommer inte fungerar helt korrekt om er webbläsares JavaScript funktion är inaktiverad.
Novel therapeutics of type-2 diabetes

Abarceo Pharma

Abarceo Pharma has identified a novel treatment of type-2 diabetes which addresses the disease at the root and allows patients to produce their insulin again, naturally.

Abarceo Pharma


Kristian Hansen

First investment year:


Business sector:

Life Science, Drug development

Investment manager: Helen Pettersson Visit website